Aquestive Therapeutics, Inc.
← Back to AQST Overview

Aquestive Therapeutics, Inc. (AQST)

Solvency & Capital Structure

Total Debt

$133.6M

Net Debt

$22.8M

Aquestive Therapeutics, Inc. currently has $133.6M in total debt. Net debt is $22.8M after cash offsets.

Financial Fundamentals

AQSTQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.130.110.020.1494.7%
2025-12-310.130.120.010.1681.9%
2025-09-300.130.13-0.00Net Cash0.1678.8%
2025-06-300.040.06-0.02Net Cash0.0943.0%
2025-03-310.040.07-0.03Net Cash0.1038.3%
2024-12-310.040.07-0.03Net Cash0.1037.5%
2024-09-300.040.08-0.04Net Cash0.1133.5%
2024-06-300.040.09-0.05Net Cash0.1230.4%
2024-03-310.030.10-0.06Net Cash0.1326.6%
2023-12-310.030.020.010.0658.0%
2023-09-300.050.020.020.0675.8%
2023-06-300.050.020.020.0679.2%
2023-03-310.050.030.020.0679.0%
2022-12-310.060.030.030.06100.7%
2022-09-300.060.020.040.05106.3%
2022-06-300.060.020.040.0699.4%
2022-03-310.060.010.040.06100.6%
2021-12-310.060.030.030.0691.0%
2021-09-300.040.030.010.0766.5%
2021-06-300.040.030.010.0763.5%
2021-03-310.040.030.010.0667.0%
2020-12-310.040.030.010.0664.4%
2020-09-300.070.020.050.05130.5%
2020-06-300.070.030.040.06103.0%
2020-03-310.060.040.030.06100.7%
2019-12-310.060.050.010.0876.9%
2019-09-300.060.020.040.05122.4%
2019-06-300.050.020.030.0594.1%
2019-03-310.050.040.010.0770.0%
2018-12-310.050.06-0.01Net Cash0.0954.3%
2018-09-300.050.06-0.02Net Cash0.0952.0%
2018-06-300.050.010.040.04116.5%
2018-03-310.050.020.030.0599.7%
2017-12-310.050.020.030.04105.5%
2017-03-310.000.01-0.01Net Cash0.00